Clearside Biomedical, Inc. Banner Image

Clearside Biomedical, Inc.

  • Ticker CLSD
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Clearside Biomedical, Inc. Logo Image
  • 11-50 Employees
  • Based in Alpharetta, Georgia
Clearside Biomedical, Inc. is a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases. Clearside’s proprietary SCS Microinjector® targets the suprachoroidal space (SCS®) and offers unique access to the macula, retina and choroid where sight-threatening disease often occurs. The Company’sMore SCS injection platform is an inherently flexible, in-office, non-surgical procedure, intended to provide targeted delivery to the site of disease and to work with both established and new formulations of medications, as well as future therapeutic innovations such as gene therapy.
4.8 / 5.0 (147)

Clearside Biomedical, Inc. reports have an aggregate usefulness score of 4.8 based on 147 reviews.

Clearside Biomedical, Inc.

Most Recent Annual Report

Clearside Biomedical, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Clearside Biomedical, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!